ID: ALA193374

Max Phase: Preclinical

Molecular Formula: C21H15NO6

Molecular Weight: 377.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1ccc(Oc2cccc(C(=O)Nc3ccccc3C(=O)O)c2)cc1

Standard InChI:  InChI=1S/C21H15NO6/c23-19(22-18-7-2-1-6-17(18)21(26)27)14-4-3-5-16(12-14)28-15-10-8-13(9-11-15)20(24)25/h1-12H,(H,22,23)(H,24,25)(H,26,27)

Standard InChI Key:  VOHDOXUHCCVGJN-UHFFFAOYSA-N

Associated Targets(non-human)

Beta-ketoacyl-ACP synthase III 89 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 377.35Molecular Weight (Monoisotopic): 377.0899AlogP: 4.13#Rotatable Bonds: 6
Polar Surface Area: 112.93Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.48CX Basic pKa: CX LogP: 4.53CX LogD: -1.79
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.60Np Likeness Score: -0.91

References

1. Nie Z, Perretta C, Lu J, Su Y, Margosiak S, Gajiwala KS, Cortez J, Nikulin V, Yager KM, Appelt K, Chu S..  (2005)  Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.,  48  (5): [PMID:15743201] [10.1021/jm049141s]
2. Singh S, Soni LK, Gupta MK, Prabhakar YS, Kaskhedikar SG..  (2008)  QSAR studies on benzoylaminobenzoic acid derivatives as inhibitors of beta-ketoacyl-acyl carrier protein synthase III.,  43  (5): [PMID:17707951] [10.1016/j.ejmech.2007.06.018]

Source